La bourse est fermée
  • CAC 40

    4 909,64
    +58,26 (+1,20 %)
     
  • Euro Stoxx 50

    3 198,86
    +27,45 (+0,87 %)
     
  • Dow Jones

    28 335,57
    -28,09 (-0,10 %)
     
  • EUR/USD

    1,1868
    +0,0042 (+0,36 %)
     
  • Gold future

    1 903,40
    -1,20 (-0,06 %)
     
  • BTC-EUR

    10 959,65
    -14,04 (-0,13 %)
     
  • CMC Crypto 200

    260,05
    -1,40 (-0,54 %)
     
  • Pétrole WTI

    39,78
    -0,86 (-2,12 %)
     
  • DAX

    12 645,75
    +102,69 (+0,82 %)
     
  • FTSE 100

    5 860,28
    +74,63 (+1,29 %)
     
  • Nasdaq

    11 548,28
    +42,28 (+0,37 %)
     
  • S&P 500

    3 465,39
    +11,90 (+0,34 %)
     
  • Nikkei 225

    23 516,59
    +42,32 (+0,18 %)
     
  • HANG SENG

    24 918,78
    +132,65 (+0,54 %)
     
  • GBP/USD

    1,3038
    -0,0042 (-0,32 %)
     

Global Fertility Services Industry

ReportLinker
·27 min de lecture

Global Fertility Services Market to Reach $39 Billion by 2027. Amid the COVID-19 crisis, the global market for Fertility Services estimated at US$22. 7 Billion in the year 2020, is projected to reach a revised size of US$39 Billion by 2027, growing at a CAGR of 8% over the analysis period 2020-2027.

New York, Oct. 02, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Fertility Services Industry" - https://www.reportlinker.com/p05956762/?utm_source=GNW
Fresh Non-Donor, one of the segments analyzed in the report, is projected to record a 8.4% CAGR and reach US$21.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Frozen Non-Donor segment is readjusted to a revised 7.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $6.1 Billion, While China is Forecast to Grow at 12.2% CAGR

The Fertility Services market in the U.S. is estimated at US$6.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$8.9 Billion by the year 2027 trailing a CAGR of 12.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Egg and Embryo Banking Segment to Record 7.5% CAGR

In the global Egg and Embryo Banking segment, USA, Canada, Japan, China and Europe will drive the 6.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.9 Billion in the year 2020 will reach a projected size of US$3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.4 Billion by the year 2027, while Latin America will expand at a 8.9% CAGR through the analysis period. We bring years of research experience to this 7th edition of our report. The 290-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Abbott Laboratories

  • AbbVie, Inc.

  • AstraZeneca PLC

  • Bristol-Myers Squibb Company

  • CooperSurgical, Inc.

  • Cryos International ApS

  • Eli Lilly and Company

  • EMD Serono, Inc.

  • Ferring Pharmaceuticals, Inc.

  • INVO Bioscience

  • Irvine Scientific

  • Ivftech Aps

  • Medical Electronic Systems, LLC.

  • Merck KGaA

  • Novartis AG

  • Pantec Biosolutions AG

  • Pfizer, Inc.

  • Sanofi SA

  • VIVUS, Inc.

  • Xytex Corporation




Read the full report: https://www.reportlinker.com/p05956762/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Fertility Competitor Market Share Scenario Worldwide (in %):
2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Fertility Services
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 2: World Historic Review for Fertility Services by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 3: World 15-Year Perspective for Fertility Services by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Fresh Non-Donor by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 5: World Historic Review for Fresh Non-Donor by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 6: World 15-Year Perspective for Fresh Non-Donor by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Frozen Non-Donor
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 8: World Historic Review for Frozen Non-Donor by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 9: World 15-Year Perspective for Frozen Non-Donor by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Egg and Embryo
Banking by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027

Table 11: World Historic Review for Egg and Embryo Banking by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 12: World 15-Year Perspective for Egg and Embryo Banking
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Fresh Donor by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 14: World Historic Review for Fresh Donor by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 15: World 15-Year Perspective for Fresh Donor by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Frozen Donor by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 17: World Historic Review for Frozen Donor by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 18: World 15-Year Perspective for Frozen Donor by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Fertility Clinics
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 20: World Historic Review for Fertility Clinics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 21: World 15-Year Perspective for Fertility Clinics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Hospitals by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 23: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019

Table 24: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Surgical Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027

Table 26: World Historic Review for Surgical Centers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 27: World 15-Year Perspective for Surgical Centers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Clinical Research
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027

Table 29: World Historic Review for Clinical Research
Institutes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019

Table 30: World 15-Year Perspective for Clinical Research
Institutes by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2020 &
2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Fertility Market Share (in %) by Company: 2019 & 2025
Market Analytics
Table 31: USA Current & Future Analysis for Fertility Services
by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027

Table 32: USA Historic Review for Fertility Services by Segment -
Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking,
Fresh Donor and Frozen Donor Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 33: USA 15-Year Perspective for Fertility Services by
Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 34: USA Current & Future Analysis for Fertility Services
by End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 35: USA Historic Review for Fertility Services by End-Use -
Fertility Clinics, Hospitals, Surgical Centers and Clinical
Research Institutes Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 36: USA 15-Year Perspective for Fertility Services by
End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

CANADA
Table 37: Canada Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 38: Canada Historic Review for Fertility Services by
Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 39: Canada 15-Year Perspective for Fertility Services by
Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 40: Canada Current & Future Analysis for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 41: Canada Historic Review for Fertility Services by
End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 42: Canada 15-Year Perspective for Fertility Services by
End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

JAPAN
Table 43: Japan Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 44: Japan Historic Review for Fertility Services by
Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 45: Japan 15-Year Perspective for Fertility Services by
Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 46: Japan Current & Future Analysis for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 47: Japan Historic Review for Fertility Services by
End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 48: Japan 15-Year Perspective for Fertility Services by
End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

CHINA
Table 49: China Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 50: China Historic Review for Fertility Services by
Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 51: China 15-Year Perspective for Fertility Services by
Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 52: China Current & Future Analysis for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 53: China Historic Review for Fertility Services by
End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 54: China 15-Year Perspective for Fertility Services by
End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

EUROPE
Market Facts & Figures
European Fertility Market: Competitor Market Share Scenario
(in %) for 2019 & 2025
Market Analytics
Table 55: Europe Current & Future Analysis for Fertility
Services by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027

Table 56: Europe Historic Review for Fertility Services by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 57: Europe 15-Year Perspective for Fertility Services by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2020 & 2027

Table 58: Europe Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 59: Europe Historic Review for Fertility Services by
Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 60: Europe 15-Year Perspective for Fertility Services by
Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 61: Europe Current & Future Analysis for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 62: Europe Historic Review for Fertility Services by
End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 63: Europe 15-Year Perspective for Fertility Services by
End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

FRANCE
Table 64: France Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 65: France Historic Review for Fertility Services by
Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 66: France 15-Year Perspective for Fertility Services by
Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 67: France Current & Future Analysis for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 68: France Historic Review for Fertility Services by
End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 69: France 15-Year Perspective for Fertility Services by
End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

GERMANY
Table 70: Germany Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 71: Germany Historic Review for Fertility Services by
Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 72: Germany 15-Year Perspective for Fertility Services by
Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 73: Germany Current & Future Analysis for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 74: Germany Historic Review for Fertility Services by
End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 75: Germany 15-Year Perspective for Fertility Services by
End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

ITALY
Table 76: Italy Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 77: Italy Historic Review for Fertility Services by
Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 78: Italy 15-Year Perspective for Fertility Services by
Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 79: Italy Current & Future Analysis for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 80: Italy Historic Review for Fertility Services by
End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 81: Italy 15-Year Perspective for Fertility Services by
End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

UNITED KINGDOM
Table 82: UK Current & Future Analysis for Fertility Services
by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027

Table 83: UK Historic Review for Fertility Services by Segment -
Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking,
Fresh Donor and Frozen Donor Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 84: UK 15-Year Perspective for Fertility Services by
Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 85: UK Current & Future Analysis for Fertility Services
by End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes - Independent Analysis of Annual
Sales in US$ Million for the Years 2020 through 2027

Table 86: UK Historic Review for Fertility Services by End-Use -
Fertility Clinics, Hospitals, Surgical Centers and Clinical
Research Institutes Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019

Table 87: UK 15-Year Perspective for Fertility Services by
End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

SPAIN
Table 88: Spain Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 89: Spain Historic Review for Fertility Services by
Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 90: Spain 15-Year Perspective for Fertility Services by
Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 91: Spain Current & Future Analysis for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 92: Spain Historic Review for Fertility Services by
End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 93: Spain 15-Year Perspective for Fertility Services by
End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

RUSSIA
Table 94: Russia Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 95: Russia Historic Review for Fertility Services by
Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 96: Russia 15-Year Perspective for Fertility Services by
Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 97: Russia Current & Future Analysis for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 98: Russia Historic Review for Fertility Services by
End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 99: Russia 15-Year Perspective for Fertility Services by
End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

REST OF EUROPE
Table 100: Rest of Europe Current & Future Analysis for
Fertility Services by Segment - Fresh Non-Donor, Frozen
Non-Donor, Egg and Embryo Banking, Fresh Donor and Frozen Donor -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027

Table 101: Rest of Europe Historic Review for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019

Table 102: Rest of Europe 15-Year Perspective for Fertility
Services by Segment - Percentage Breakdown of Value Sales for
Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking,
Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 103: Rest of Europe Current & Future Analysis for
Fertility Services by End-Use - Fertility Clinics, Hospitals,
Surgical Centers and Clinical Research Institutes - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 104: Rest of Europe Historic Review for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 105: Rest of Europe 15-Year Perspective for Fertility
Services by End-Use - Percentage Breakdown of Value Sales for
Fertility Clinics, Hospitals, Surgical Centers and Clinical
Research Institutes for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 106: Asia-Pacific Current & Future Analysis for Fertility
Services by Geographic Region - Australia, India, South Korea
and Rest of Asia-Pacific Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2020 through 2027

Table 107: Asia-Pacific Historic Review for Fertility Services
by Geographic Region - Australia, India, South Korea and Rest
of Asia-Pacific Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019

Table 108: Asia-Pacific 15-Year Perspective for Fertility
Services by Geographic Region - Percentage Breakdown of Value
Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2020 & 2027

Table 109: Asia-Pacific Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 110: Asia-Pacific Historic Review for Fertility Services
by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 111: Asia-Pacific 15-Year Perspective for Fertility
Services by Segment - Percentage Breakdown of Value Sales for
Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo Banking,
Fresh Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 112: Asia-Pacific Current & Future Analysis for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 113: Asia-Pacific Historic Review for Fertility Services
by End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 114: Asia-Pacific 15-Year Perspective for Fertility
Services by End-Use - Percentage Breakdown of Value Sales for
Fertility Clinics, Hospitals, Surgical Centers and Clinical
Research Institutes for the Years 2012, 2020 & 2027

AUSTRALIA
Table 115: Australia Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 116: Australia Historic Review for Fertility Services by
Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 117: Australia 15-Year Perspective for Fertility Services
by Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 118: Australia Current & Future Analysis for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 119: Australia Historic Review for Fertility Services by
End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 120: Australia 15-Year Perspective for Fertility Services
by End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

INDIA
Table 121: India Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg
and Embryo Banking, Fresh Donor and Frozen Donor - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027

Table 122: India Historic Review for Fertility Services by
Segment - Fresh Non-Donor, Frozen Non-Donor, Egg and Embryo
Banking, Fresh Donor and Frozen Donor Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019

Table 123: India 15-Year Perspective for Fertility Services by
Segment - Percentage Breakdown of Value Sales for Fresh
Non-Donor, Frozen Non-Donor, Egg and Embryo Banking, Fresh
Donor and Frozen Donor for the Years 2012, 2020 & 2027

Table 124: India Current & Future Analysis for Fertility
Services by End-Use - Fertility Clinics, Hospitals, Surgical
Centers and Clinical Research Institutes - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027

Table 125: India Historic Review for Fertility Services by
End-Use - Fertility Clinics, Hospitals, Surgical Centers and
Clinical Research Institutes Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019

Table 126: India 15-Year Perspective for Fertility Services by
End-Use - Percentage Breakdown of Value Sales for Fertility
Clinics, Hospitals, Surgical Centers and Clinical Research
Institutes for the Years 2012, 2020 & 2027

SOUTH KOREA
Table 127: South Korea Current & Future Analysis for Fertility
Services by Segment - Fresh Non-Donor, Frozen Non-Donor, Egg

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05956762/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001